MICROSCOPIC POLYANGIITIS MARKET ANALYSIS

Microscopic Polyangiitis Market, by Drug (Rituximab, Azathioprine, Cyclophosphamide, Prednisone, Pipeline drugs (Abatacept and IFX 1), and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2529
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Microscopic Polyangiitis Market Key Players

Some of the key players operating in the global microscopic polyangiitis market include Genentech, Inc., Celltrion, Inc., InflaRx N.V., ChemoCentryx Inc., Bristol-Myers Squibb Company, Teijin Pharma Ltd, Amerigen Pharmaceuticals Limited, Sandoz International GmbH (Novartis Division), and TTY Biopharm Company Ltd.